Are oral contraceptives masking symptoms of chlamydial cervicitis and pelvic inflammatory disease?

European Journal of Contraception and Reproductive Health Care

Volumn 3, Issue 1, 1998, Pages 41-43

  Mardh P A ^a   Hogg, B ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Chlamydia trachomatis; Ectopic pregnancy; Intrauterine device; Oral contraceptives; Pelvic inflammatory disease

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; ECTOPIC PREGNANCY; EUROPE; FEMALE; FEMALE INFERTILITY; HUMAN; PELVIC INFLAMMATORY DISEASE; PREGNANCY; REVIEW; UTERINE CERVICITIS;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CONTRACEPTIVES, ORAL; EUROPE; FEMALE; HUMANS; INFERTILITY, FEMALE; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PREGNANCY, ECTOPIC; UTERINE CERVICITIS;

EID: 0032013149     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.3109/13625189809167484     Document Type: Article

References (14)

1. Wölner-Hansen P, Svensson L, Mårdh P-A. Laparoscopic findings and contraceptive use in women with signs and symptoms suggestive of acute salpingitis. Obstet Gynecol 1989; 66: 233-8
2. Ness RB, Kedar LM, Soper DL, et al. Oral contraception and the recognition of endometritis.Am J Obstet Gynecol 1997; 176: 580-5
3. Paavonen J, Weström L. Diagnosis of pelvic inflammatory disease. In Berger G ,Weström L, eds. Pelvic Inflammatory Disease. New York: Raven Press, 1992: 49-76
4. Eddomes HA. 'Pipelle'. A more acceptable technique for outpatient endometrial biopsy. Br J Obstet Gynaecol 1990; 97: 961
5. Wölner-Hansen P. Silent pelvic inflammatory disease; is it overstated? Obstet Gynecol 1995; 86: 321-5
6. Mårdh P-A, Genc M. Is Europe ready for screening for genital chlamydial infections. In Proceedings of 3rd European Chlamydia Meeting. Vienna: University of Vienna, 1996: 381-4
7. Weström L. Sexually transmitted diseases and infertility. Sex Transm Dis 1994; 21: 32-7
8. Wölner-Hansen P. Oral contraceptive use modifies the manifestations of pelvic inflammatory disease. Br J Obstet Gynaecol 1986; 93: 619-24
9. Wölner-Hansen P, Mårdh P-A. In vitro tests of the adherence of Chlamydia trachomatis to human spermatozoa. Fertil Steril 1984; 42: 102-7
10. Straube W. Veränderungen in immunsystem durch hormonale Kontrazeption. Z Ärtztl Fortbildung 1990; 84; 51-3
11. Krettek JE. Chlamydia trachomatis in patients who used oral contraceptives and had intermenstrual spotting. Obstet Gynecol 1993; 7: 28-31
12. Basseri M, Mårdh P-A, Domeika M, et al. Multiplex Amplicor screening PCR for Chlamydia trachomatis and Neisseria gonorrhoeae in women attending non-sexually transmitted disease clinics. J Clin Microbiol 1997; 35: 2556-60
13. Nilsson U, Shubnikova M, Hellberg D, et al. Sexual behaviour risk factors associated with bacterial vaginosis and Chlamydia trachomatis. Sex Transm Dis 1997; 24: 241-6
14. Toivonen J. Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levorgestrel- and copper-releasing devices. Obstet Gynecol 1990; 77: 261-4